The demand for medical and industrial oxygen in India has surged significantly over the past few years, driven by expanding healthcare infrastructure, rising industrial applications, and the increased focus on self-reliance in critical medical supplies post-pandemic. According to Mordor Intelligence, the India medical gas market was valued at USD 1.3 billion in 2023 and is projected to grow at a CAGR of over 10.5% during the forecast period 2024–2029. This growth is mirrored in the industrial gas segment, where rising manufacturing and metallurgical activities amplify the need for reliable oxygen supply. With government initiatives like ‘Make in India’ and the National Oxygen Stewardship Program, domestic manufacturing of oxygen generation systems has gained momentum. As a result, Indian OEMs are scaling up production, enhancing technology, and adopting energy-efficient designs to meet both domestic and global demands. Against this backdrop, identifying the top 10 oxygen plant manufacturers in India becomes critical for healthcare providers, industries, and procurement decision-makers seeking reliable, high-performance, and cost-effective solutions. These manufacturers are not only contributing to national resilience but are also positioning India as a key player in the global oxygen generation ecosystem.
Top 10 Oxygen Plant India Manufacturers (2026 Audit Report)
(Ranked by Factory Capability & Trust Score)
Expert Sourcing Insights for Oxygen Plant India

H2: Market Trends for Oxygen Plants in India (2026 Outlook)
As India progresses toward 2026, the oxygen plant market is witnessing significant transformation driven by healthcare modernization, industrial expansion, and policy reforms. The following analysis outlines key trends shaping the oxygen plant sector in India over the coming years:
1. Post-Pandemic Healthcare Infrastructure Expansion
The severe oxygen shortages during the 2021 COVID-19 wave acted as a catalyst for government and private investment in medical oxygen infrastructure. By 2026, this momentum continues, with central and state governments implementing Phase-II of the PM Ayushman Bharat Health Infrastructure Mission. This includes setting up over 1,500 new Pressure Swing Adsorption (PSA) oxygen plants in district hospitals and rural health centers, particularly in underserved states like Bihar, Jharkhand, and Odisha.
2. Growth in On-Site Oxygen Generation
Hospitals and clinics are increasingly shifting from liquid oxygen deliveries to on-site oxygen generation systems due to reliability and cost-efficiency. By 2026, over 60% of mid- to large-sized private hospitals are expected to adopt PSA or VPSA (Vacuum Pressure Swing Adsorption) oxygen plants. This trend is supported by falling equipment costs and advancements in modular, energy-efficient plant designs.
3. Industrial Demand Driving Market Diversification
Beyond healthcare, industrial applications of oxygen — including steel manufacturing, wastewater treatment, and chemical synthesis — are expanding. India’s push for green steel and cleaner industrial processes is increasing demand for high-purity oxygen. The steel sector alone is projected to account for nearly 40% of industrial oxygen consumption by 2026, led by companies like JSW Steel and Tata Steel investing in captive oxygen plants.
4. Government Incentives and Regulatory Support
The Ministry of Health and Family Welfare, in collaboration with the Department of Pharmaceuticals, has introduced subsidies and tax breaks for hospitals installing oxygen generation plants. Additionally, new Bureau of Indian Standards (BIS) norms for oxygen purity (IS 8324:2023) ensure quality and safety, boosting consumer confidence and encouraging formal market participation.
5. Rise of Domestic Manufacturing and Technology Partnerships
To reduce import dependency, Indian manufacturers such as Inox Air Products, Linde India, and Matheson Gas are scaling up local production of oxygen plant components. Partnerships with German and Japanese firms are facilitating technology transfer in membrane and adsorption systems, enabling India to develop cost-competitive, high-efficiency plants.
6. Integration of IoT and Remote Monitoring
By 2026, smart oxygen plants equipped with IoT sensors and cloud-based monitoring systems are becoming standard. These systems enable real-time tracking of oxygen output, pressure, and maintenance alerts, improving operational efficiency and reducing downtime — a critical advantage for remote and rural healthcare facilities.
7. Sustainability and Energy Efficiency Focus
With rising electricity costs and environmental concerns, manufacturers are introducing solar-powered and energy-optimized PSA plants. Pilot projects in Rajasthan and Gujarat are testing hybrid solar-oxygen plants, aligning with India’s net-zero goals and attracting green financing.
Conclusion
The Indian oxygen plant market in 2026 is poised for sustained growth, driven by structural healthcare reforms, industrial modernization, and technological innovation. The convergence of policy support, rising domestic demand, and digital integration positions the sector for robust expansion, with a projected CAGR of 12–14% from 2023 to 2026. Stakeholders who invest in scalable, efficient, and compliant solutions will be best positioned to capture emerging opportunities.

Certainly! Here’s a concise and informative overview of the common pitfalls when sourcing oxygen plants in India, particularly focusing on quality and intellectual property (IP) concerns, structured using H₂ as a thematic reference (though H₂ typically refers to hydrogen, we’ll use it metaphorically or contextually where relevant, while focusing on oxygen plant sourcing):
Common Pitfalls Sourcing Oxygen Plants in India: Quality & IP Risks (H₂ Contextual Lens)
While H₂ (hydrogen) is not directly involved in standard oxygen generation (via PSA or VPSA), the growing convergence of gas infrastructure—especially in clean energy—means oxygen plants may be co-located or integrated with hydrogen production units (e.g., in electrolyzer-based H₂ systems or syngas processes). Thus, sourcing oxygen plants in India must consider broader industrial integration, including future H₂ compatibility.
1. Quality Pitfalls
a. Substandard Materials & Components
– Many Indian suppliers use low-grade molecular sieves (e.g., inferior 13X or carbon molecular sieves), leading to reduced O₂ purity (<90%) and shorter lifespan.
– Compressors, valves, and control systems may be sourced from non-certified vendors, increasing downtime.
– Risk: Poor performance in critical applications (medical, industrial).
b. Inadequate Design & Engineering
– Some manufacturers copy designs without proper engineering validation.
– Lack of site-specific customization (humidity, altitude, ambient temperature).
– Example: Plants in high-altitude regions (e.g., Ladakh) may fail if not designed for thin air.
c. Inconsistent Compliance & Certification
– Not all suppliers adhere to IS 8150, ISO 7396-1 (medical gas), or ASME standards.
– Medical oxygen plants may lack CDSCO or FDA India approvals.
– H₂ link: If the oxygen plant supports H₂ production (e.g., in ASU for cryogenic H₂), quality lapses can compromise safety.
d. Poor After-Sales & Maintenance Support
– Delayed spare parts delivery and lack of trained technicians.
– Remote monitoring often missing or non-functional.
2. Intellectual Property (IP) Risks
a. Reverse-Engineered or Cloned Technology
– Several Indian manufacturers replicate foreign PSA/VPSA designs without licensing.
– Use of patented sieve bed configurations or control algorithms without authorization.
– Risk: Legal exposure for end-users if IP infringement is traced to supplied equipment.
b. Lack of Transparency in Technology Source
– Vendors may claim “indigenous technology” but use foreign designs under gray licensing.
– No documentation on IP ownership or freedom-to-operate (FTO).
c. Weak Protection of Custom Designs
– If a buyer co-develops a plant design (e.g., H₂-compatible O₂ unit), IP may not be properly assigned or protected.
– Contracts often lack clauses on IP ownership, data rights, or tech transfer.
d. Cybersecurity & Software IP (for Automated Plants)
– PLC/SCADA systems may use pirated software (e.g., Siemens TIA Portal clones).
– Risk of vulnerabilities in remote monitoring systems, especially if linked to larger H₂ energy networks.
3. H₂ Integration Considerations (Forward-Looking Pitfalls)
- Oxygen byproduct in green H₂ production: Electrolyzers produce O₂ as a byproduct. Low-quality O₂ handling systems (e.g., poor drying, storage) can create safety hazards.
- Shared infrastructure risks: If O₂ and H₂ plants share compressors or control systems, poor O₂ plant quality can affect H₂ purity and safety.
- Future-proofing: Plants not designed for H₂ service (e.g., materials not H₂-compatible) limit retrofit options.
Mitigation Strategies
| Risk | Mitigation |
|——|————|
| Poor Quality | Audit suppliers, demand third-party test reports (e.g., from NABL labs), insist on site trials. |
| IP Infringement | Conduct IP due diligence, include indemnity clauses in contracts, prefer OEMs with proven IP. |
| Compliance Gaps | Verify certifications (BIS, ISO, CE), involve third-party inspection agencies (e.g., TÜV, BV). |
| H₂ Compatibility | Specify future H₂ integration needs upfront; ensure materials and controls are compatible. |
Conclusion
Sourcing oxygen plants in India offers cost advantages but carries significant quality and IP risks, especially as industries move toward integrated systems involving H₂. Buyers must perform rigorous technical and legal due diligence, prioritize certified suppliers, and safeguard IP—particularly when oxygen plants are part of a larger clean energy (e.g., green hydrogen) ecosystem.
Pro Tip: Consider partnering with technology-licensed manufacturers (e.g., those with Air Products, Linde, or Matheson technology) rather than low-cost copycats, especially for mission-critical or H₂-linked applications.
Let me know if you’d like a supplier evaluation checklist or a sample IP clause for contracts.

H2: Logistics & Compliance Guide for Oxygen Plant Operations in India
Establishing and operating an oxygen plant in India involves a complex interplay of logistics management and regulatory compliance. This guide outlines key considerations under the heading H2: Logistics & Compliance, focusing on infrastructure, supply chain, regulatory frameworks, safety protocols, and environmental standards.
H2: Logistics & Compliance
- Regulatory Approvals and Licensing
To legally operate an oxygen plant in India, the following clearances are essential:
- Factory License: Required under the Factories Act, 1948. Issued by the State Directorate of Industrial Safety and Health (DISH) after inspection.
- Consent to Establish (CTE) and Consent to Operate (CTO): Issued by the State Pollution Control Board (SPCB) under the Air (Prevention & Control of Pollution) Act, 1981 and Water (Prevention & Control of Pollution) Act, 1974.
- Hazardous Waste Management Authorization: If the process generates hazardous waste, registration under the Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2016 is mandatory.
- Explosives Act Clearance: Since oxygen is a strong oxidizer, compliance with the Explosives Act, 1884 and rules thereunder may be required depending on storage volume and pressure.
- Fire NOC: A No Objection Certificate from the local Fire Department under the National Building Code (NBC) and state-specific fire safety regulations.
- Drug License (if for medical oxygen): Medical oxygen is classified as a drug under the Drugs and Cosmetics Act, 1940. A manufacturing license (Form 28) from the State Drug Control Authority is required. Must comply with Good Manufacturing Practices (GMP) and IS 10268:1982 (Grade A for medical oxygen).
-
BIS Certification: Oxygen cylinders must conform to Bureau of Indian Standards (BIS) IS 3104 (for seamless steel gas cylinders) and be registered under the BIS Certification Scheme.
-
Site Selection and Infrastructure Logistics
-
Proximity to Demand Centers: Locate near hospitals, industrial zones, or transport hubs to minimize distribution time and costs.
- Utility Access: Ensure reliable supply of electricity, water, and backup power (e.g., DG sets).
- Transportation Access: Choose sites accessible by road and, if possible, rail. Proximity to national highways improves logistics efficiency.
- Storage Infrastructure: Install dedicated, ventilated, and fire-safe storage areas for oxygen cylinders and cryogenic tanks. Segregate full and empty cylinders.
-
Safety Buffer Zones: Maintain mandated distances from residential areas, public roads, and other industrial units per NBC and SPCB norms.
-
Supply Chain & Distribution Logistics
-
Cylinder Management: Implement a robust system for cylinder tracking (e.g., RFID tagging), refilling, inspection, and maintenance. Follow periodic hydrostatic testing (every 5 years) as per Indian Boiler Regulations (IBR).
- Bulk Oxygen Transport: Use cryogenic tankers (for liquid oxygen) compliant with ADR (European Agreement) or national standards. Drivers and handlers must be trained in handling cryogenic materials.
- Last-Mile Delivery: Partner with certified distributors or establish a dedicated fleet for hospital and pharmacy deliveries. Prioritize routes based on medical urgency.
- Inventory Management: Maintain buffer stock (minimum 15–30 days) to handle surges (e.g., during health emergencies like the COVID-19 pandemic).
-
Cold Chain Considerations: For liquid oxygen, ensure continuous temperature control during transport and storage to prevent boil-off.
-
Safety & Operational Compliance
-
Risk Assessment: Conduct regular Process Hazard Analysis (PHA) and Safety Audits.
- Emergency Response Plan (ERP): Develop and implement an on-site ERP, including fire, leakage, and blast procedures. Train staff and conduct drills.
- PPE and Training: Provide appropriate personal protective equipment (PPE) and train staff in handling oxygen under high pressure and low temperature.
- Equipment Certification: All pressure vessels, pipelines, and valves must comply with IBR and ASME standards. Regular inspection and certification are mandatory.
-
Gas Purity Monitoring: For medical oxygen, maintain 99.5% minimum purity. Install real-time monitoring systems and conduct periodic third-party testing.
-
Environmental and Quality Compliance
-
Emissions Control: Monitor and control noise and air emissions during plant operation.
- Waste Management: Treat and dispose of waste materials (e.g., filter media, lubricants) in accordance with SPCB guidelines.
- Energy Efficiency: Adopt energy-efficient technologies (e.g., VFDs, optimized compressors) to meet Perform, Achieve and Trade (PAT) scheme requirements under the Bureau of Energy Efficiency (BEE).
-
ISO Certification: Consider ISO 13485 (for medical devices) or ISO 9001 (quality management) to enhance credibility and compliance.
-
Documentation and Record Keeping
Maintain updated records of:
– Licenses and renewals
– Maintenance logs for equipment and cylinders
– Safety training and incident reports
– Gas quality test results
– Environmental compliance reports (effluent, emissions)
– Transport manifests and delivery records
-
Recent Regulatory Trends
-
National Oxygen Stewardship Program: Encouraged by MoHFW and NITI Aayog to ensure equitable distribution during emergencies.
- Digital Monitoring: Some states mandate integration with the Online Cylinder Tracking System (OCTS) for medical gases.
- MSME Incentives: Government schemes may offer subsidies or fast-track clearances for MSMEs setting up oxygen plants.
Conclusion
Successful operation of an oxygen plant in India requires meticulous planning in both logistics and compliance. Adhering to central and state regulations, investing in safe infrastructure, and building a resilient supply chain are critical. Regular audits, staff training, and engagement with regulatory bodies ensure long-term sustainability and public safety.
Note: Regulations may vary by state. Consult the respective State Industrial Department, SPCB, and Drug Controller for region-specific requirements.
Conclusion: Sourcing an Oxygen Plant Manufacturer in India
Sourcing an oxygen plant manufacturer in India presents a strategic and cost-effective solution for industries requiring reliable and high-purity oxygen supply. India has emerged as a leading hub for the design, engineering, and manufacturing of air separation units (ASUs) and oxygen generation plants, supported by a robust industrial base, skilled workforce, and adherence to international quality standards such as ISO, CE, and ASME.
The country offers a diverse range of manufacturers—from large-scale industrial players to specialized engineering firms—capable of delivering customized oxygen plants tailored to various applications including healthcare, steel manufacturing, wastewater treatment, and pharmaceuticals. The growing demand during and after the COVID-19 pandemic has further accelerated innovation and capacity development in India’s oxygen plant sector.
Key advantages of sourcing from Indian manufacturers include competitive pricing, shorter delivery timelines, comprehensive after-sales service, and the ability to provide turnkey solutions. Additionally, many Indian companies export globally, demonstrating their capability to meet stringent international regulations and performance benchmarks.
However, due diligence is essential when selecting a manufacturer. Factors such as technological expertise, project experience, certifications, energy efficiency of the plants, and client testimonials should be carefully evaluated.
In conclusion, India stands out as a reliable and efficient destination for sourcing oxygen plants. With the right partner, businesses can secure high-performance, cost-effective, and sustainable oxygen generation solutions that meet their operational needs and long-term goals.










